Hematology AdvisorStudy Elucidates Platelet Destruction Mechanism in FNAIT

⚠️ Preclinical Evidence

FNAIT occurs when maternal antibodies target fetal platelet antigens, leading to thrombocytopenia. Multiple mechanisms have been proposed, but the dominant pathway has remained unclear.

Clinical Considerations

• Macrophage phagocytosis identified as the dominant mechanism
• IgG removal abolished platelet destruction, confirming antibody-driven pathway
• FcγRIII blockade produced strongest inhibition of platelet clearance
• Complement activation observed in only ~20% of cases
• Platelet activation and desialylation were uncommon contributors
• Humanized mouse models confirmed preservation of platelets with FcγRIII blockade

Practice Applications

• Reinforces antibody-mediated macrophage clearance as central disease mechanism
• Identifies FcγRIII as a high-priority therapeutic target
• Supports development of receptor-blocking strategies and antibody engineering approaches
• No current impact on clinical management given preclinical stage